LONG TERM OUTCOME OF PITUITARY SURGERY FOR PROLACTINOMA
LONG TERM OUTCOME OF PITUITARY SURGERY FOR PROLACTINOMA
批准号:
6304973
负责人:
ROBERT A ADLER
金额:
$0.06万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-12-01 至 2000-11-30
中文摘要
对1985年以前切除过脑垂体瘤的病人的幸福感的测定。这将表明患者在手术后10到30年的情况如何。垂体腺瘤的两个最常见的原因是催乳素瘤和临床上无功能的肿瘤,每种肿瘤约占所有肿瘤的30%-40%。催乳素瘤是一种年轻女性的疾病,是最常见的一种激素分泌过多的脑垂体瘤。在确定接受脑下垂体手术切除肿瘤的患者后,将评估临时病史,包括产科病史、进一步治疗的病史和症状的复发。复发的解剖学和生理学证据将通过体检来确定。将进行胰岛素、甲氧氯丙胺和促甲状腺激素释放激素(TRH)的激素刺激试验,以确定脑下垂体激素的储备。为了确定垂体腺的解剖结构,将进行成像程序(计算机断层扫描或磁共振成像)以及视野检查。将进行骨密度测试,以确定患骨质疏松症的风险。患者将在临床研究中心停留几天。生活质量将通过使用诺丁汉健康概况(NHP)、霍普金斯症状检查表(HSCL)和心理综合幸福感指数进行评估。溴隐亭自1978年以来一直在美国使用,降低了大多数患者的血清催乳素水平。80-90%的患者能耐受治疗,血清PRL降低,症状减轻或消失,肿瘤缩小。但停药后症状恢复,血清PRL水平升高至治疗前水平(5)。有人担心,多年的治疗(可能是50-60年)可能会产生不良后果。
英文摘要
The determination of the well-being of patients who have had the removal of a pituitary tumor prior to 1985. This will indicate how well patients have fared ten to thirty years after the surgery. The two most common causes of pituitary adenomas are prolactinoma and clinically non-functioning tumors, where each comprises about 30-40% of all tumors. Prolactinoma, a disorder of young women, is the most common of the pituitary tumors with excess secretion of a hormone. After the identification of patients who underwent pituitary surgery for removal of tumors, the interim history, including obstetrical history, history of further treatment, and recurrence of symptoms, will be evaluated. Anatomic and physiologic evidence of recurrence will be determined by physical examination. Hormone stimulation tests with insulin, metoclopromide, and thyrotropin releasing hormone (TRH) will be given to determone the reserve of pituitary hormones. To determine the anatomy of the pitutary gland, an imaging procedure (computerized tomography or magnetic resonance imaging) will be given as well as a visual field examination. A bone mineral density test will be done to tell the risk of osteoporosis. Patients will remain in the Clinical Research Center for several days. Quality of life will be evaluated by using the Nottingham Health Profile (NHP), the Hopkins Symptom Checklist (HSCL), and the Psychological General Well-Being Index. Bromocriptine has been used in the United States since 1978, lowering the serum PRL in the majority of patients. 80-90% of the patients can tolerate treatment and have reduction in serum PRL, diminution or disappearance of symptoms, and shrinkage of the tumor. But withdrwawl of the medication leads to return of symptoms and increase of the serum PRL level toward the pre-therapy level (5). There is concern that treatment for many years (perhaps 50-60), could have adverse consequences.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
LONG TERM OUTCOME OF PITUITARY SURGERY FOR PROLACTINOMA
-
批准号:6218475
-
项目类别:
-
资助金额:$0.06万
-
财政年份:1998
-
负责人:ROBERT A ADLER
-
依托单位:
LONG TERM OUTCOME OF PITUITARY SURGERY FOR PROLACTINOMA
-
批准号:6114882
-
项目类别:
-
资助金额:$3.45万
-
财政年份:1998
-
负责人:ROBERT A ADLER
-
依托单位:
LONG TERM OUTCOME OF PITUITARY SURGERY FOR PROLACTINOMA
-
批准号:6276117
-
项目类别:
-
资助金额:$3.31万
-
财政年份:1997
-
负责人:ROBERT A ADLER
-
依托单位:
LONG TERM OUTCOME OF PITUITARY SURGERY FOR PROLACTINOMA
-
批准号:6246007
-
项目类别:
-
资助金额:$2.76万
-
财政年份:1997
-
负责人:ROBERT A ADLER
-
依托单位:
海外基金